StockTipsArenaBeta

BUY Rossari Biotech Limited — Deven Choksey, DRChoksey

BUYRossari Biotech Limited
Rossari Biotech share price target & all analyst calls

byDeven Choksey, DRChokseyHorizon: NA (inferred 1 year)25 Jul 2025via Institutional / Brokerage Research

Entry₹716.65Inferred
Target₹860
Total upside +20.00% (call closed)
Stop lossNot given
At expiry₹489.824 Jul 2026, 3:30 pm
Expired-31.65%
Follow Deven Choksey for new calls(75% target hit, 63 closed calls)Get alertsWatch ROSSARI for new buy/sell callsGet alertsSee 7 active Long-term calls on ROSSARISee 212 active Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 24 Jul 2026
3 supporting1 neutral0 opposing
Supports the BUY call (3)

Rossari Biotech expects growth to pick up as new capacity comes online

NewsCnbc-Tv18·20 Jul · 3d ago

(opens in new tab)

1 other SEBI-registered advisor has an active long-term BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·21 Jul · 3d ago

Rossari Biotech announced its Q1 FY27 financial results, reporting highest-ever quarterly revenue of Rs. 697.2 crore (up 28% YoY) and EBITDA of Rs. 80.6 crore (up 19% YoY). PAT increased by 4% to Rs.

BSE · Company Update·19 Jul · 4d ago

(opens in new tab)
Neutral / worth noting (1)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Rossari Biotech

All analyst calls on Rossari Biotech

More from Deven Choksey, DRChoksey

Every call and its outcome